Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Epothilone D

Generic Name: Epothilone D

Drug Type: Small Molecule

Chemical Formula: C_₂₇H_₄₁NO_₅S

CAS Number: 189453-10-9

Unique Ingredient Identifier: T0358E0YUF

Overview

No overview information available.

Background

No background information available.

Indication

Investigated for use/treatment in colorectal cancer, lung cancer, breast cancer, solid tumors, and prostate cancer.

Associated Conditions

No associated conditions information available.

Clinical Trials

A Study of Epothilone D in Combination With Herceptin (Trastuzumab) in Patients With HER-2 Positive Advanced or Metastatic Breast Cancer

Phase 1

Completed

Posted: 2006/06/16

Sponsor:Hoffmann-La Roche

ID:NCT00337649

Study of KOS-862 (Epothilone D) in Metastatic Prostate Cancer

Phase 2

Terminated

Posted: 2005/02/24

Sponsor:Bristol-Myers Squibb

ID:NCT00104130

Epothilone D in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Platinum-Based Chemotherapy

Phase 2

Completed

Posted: 2004/04/08

Sponsor:Memorial Sloan Kette...

ID:NCT00081107

Effectiveness of KOS-862 in the Treatment of Lung Cancer

Phase 2

Terminated

Posted: 2004/04/07

Sponsor:Bristol-Myers Squibb

ID:NCT00080509

Epothilone D as Second-Line Treatment for Patients With Advanced or Metastatic Refractory Colorectal Cancer

Phase 2

Completed

Posted: 2004/02/11

Sponsor:Memorial Sloan Kette...

ID:NCT00077259

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy